Thromboelastography to Support Clinical Decision Making in Patients with Peripheral Artery Disease.

Anahita Dua, Isabella Cieri, Adriana Rodriguez, Shiv Patel, Dawn Barberi, Joao D Dias, Jan Hartmann

Abstract readComment

In one paragraph

Article in Diagnostics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Anahita DuaDivision of Vascular Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.

Isabella CieriMassachusetts General Hospital, Boston, MA 02114, USA.

Adriana RodriguezMassachusetts General Hospital, Boston, MA 02114, USA.

Shiv PatelMassachusetts General Hospital, Boston, MA 02114, USA.

Dawn BarberiGlobal Medical Office (GMO), Haemonetics Corporation, Boston, MA 02110, USA.

Joao D DiasGlobal Medical Office (GMO), Haemonetics Corporation, Boston, MA 02110, USA.ORCID 0000-0002-1150-4357

Jan HartmannGlobal Medical Office (GMO), Haemonetics Corporation, Boston, MA 02110, USA.ORCID 0000-0003-4978-8014

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peripheral artery disease (PAD) leads to reduced blood flow, primarily affecting the vessels of lower extremities. Symptoms include pain, cramping and reduced functional capacity, and patients are also at increased risk of cardiovascular complications and mortality. Postoperative medical management in PAD patients includes the use of antiplatelet and antithrombotic medications, which help to prevent postoperative graft and stent thrombosis and associated adverse effects. Despite extensive research, there is little consensus on the best strategy or medication regimen for patients with PAD or on monitoring strategies for the antithrombotic therapies. Thromboelastography, with the adjunct of platelet function assessment, is well established for providing real-time assessment of coagulation and platelet function in patients undergoing cardiovascular surgery or cardiovascular procedures. TEG

Indexed as

antiplatelet therapyantithrombotic therapyhypercoagulabilitymajor adverse cardiovascular events (MACE)peripheral artery disease (PAD)personalized medicineplatelet functionPlateletMapping® assayrevascularizationthromboelastography (TEG®)

Identifiers

PMID41464114

DOI10.3390/diagnostics15243113

PMCPMC12731982

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.